tanshinone has been researched along with Cirrhosis in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 12 (60.00) | 24.3611 |
2020's | 7 (35.00) | 2.80 |
Authors | Studies |
---|---|
Wang, X; Xiao, C; Xu, Z; Yan, N; Yang, J | 1 |
Fan, X; Hou, Y; Li, F; Piao, J; Sun, J; Wei, Y; Xu, Z; Yao, W; Zheng, H | 1 |
Huang, D; Wu, M; Yang, F; Ye, C | 1 |
Chen, Z; Feng, H; Gao, H; Peng, C; Tang, S; Xie, C; Yuan, Q; Zhang, Z | 1 |
Hu, F; Jiang, Y; Li, M; Li, Q; Shen, C; Yang, J | 1 |
Ding, K; He, L; Qian, X; Wang, S; Xu, S; Xu, X; Zhang, L | 1 |
Bi, Z; Wang, Y; Zhang, W | 1 |
Chen, R; Chen, W; Huang, X; Rui, Q | 1 |
Cao, L; Fu, X; Huang, B; Lin, F; Lin, Y; Yang, J | 1 |
Huang, L; Zheng, M; Zhou, Y; Zhu, J; Zhu, M; Zou, R | 1 |
Han, B; Pang, H; Peng, Z; Yu, T | 1 |
Huang, X; Li, Q; Sheng, L; Yang, M; Yu, Q; Zhu, M | 1 |
Li, H; Li, P; Li, S; Shi, Q; Yang, F; Zhao, L | 1 |
Cheng, X; Huang, RH; Lin, X; Wang, DT; Yang, YJ; Zhang, ZH | 1 |
Gong, R; Jiang, C; Jin, B; Shao, Q; Xu, B; Zhang, M | 1 |
Hu, XR; Huang, DD; Hung, ZA; Shu, M; Zhang, S | 1 |
Tang, J; Zhan, C; Zhou, J | 1 |
Chen, JW; Fang, J; Gao, J; Huang, HQ; Liu, PQ; Tang, FT; Wang, P; Xu, SW; Zhou, SG | 1 |
Bao, Y; Fang, J; Gao, J; Liu, P; Mou, YG; Pi, R; Wang, P; Wu, X; Zhou, S | 1 |
Li, Z; Zhan, C; Zhang, L; Zhou, D | 1 |
2 review(s) available for tanshinone and Cirrhosis
Article | Year |
---|---|
Renoprotective Effects of Tanshinone IIA: A Literature Review.
Topics: Abietanes; Animals; Fibrosis; Humans; Kidney; Kidney Diseases; Plant Extracts | 2023 |
A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Drugs, Chinese Herbal; Fibrosis; Humans; Medicine, Chinese Traditional; Salvia miltiorrhiza; Signal Transduction | 2021 |
18 other study(ies) available for tanshinone and Cirrhosis
Article | Year |
---|---|
Tanshinone IIA from Salvia miltiorrhiza exerts anti-fibrotic effects on cardiac fibroblasts and rat heart tissues by suppressing the levels of pro-fibrotic factors: The key role of miR-618.
Topics: Abietanes; Animals; Fibroblasts; Fibrosis; Heart; MicroRNAs; Myocardium; Rats; Salvia miltiorrhiza | 2022 |
Hierarchically structured microcapsules for oral delivery of emodin and tanshinone IIA to treat renal fibrosis.
Topics: Abietanes; Animals; Capsules; Emodin; Fibrosis; Rats | 2022 |
Tanshinone I attenuates fibrosis in fibrotic kidneys through down-regulation of inhibin beta-A.
Topics: Abietanes; Animals; Disease Models, Animal; Down-Regulation; Female; Fibrosis; Humans; Inhibins; Kidney; Kidney Diseases; Male; Mice; Rats; Ureteral Obstruction | 2022 |
Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
Topics: Abietanes; Animals; Bleomycin; Cell Line; Disease Models, Animal; Endothelial Cells; Endothelium; Epithelial-Mesenchymal Transition; Female; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Salvia miltiorrhiza; Scleroderma, Systemic; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis.
Topics: Abietanes; Animals; Diabetic Nephropathies; eIF-2 Kinase; Endoplasmic Reticulum Stress; Fibrosis; Hypoglycemic Agents; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin | 2020 |
Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats.
Topics: Abietanes; Actins; Animals; Antioxidants; Collagen; Fibrosis; Heart Failure; Male; Malondialdehyde; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta | 2021 |
Effects of tanshinone IIA on the regulation of renal proximal tubular fibrosis.
Topics: Abietanes; Actins; Cadherins; Cell Line; Epithelial Cells; Fibronectins; Fibrosis; Humans; Kidney Tubules, Proximal; Renal Insufficiency, Chronic; RNA, Messenger; Snail Family Transcription Factors; Vimentin | 2017 |
Tanshinone IIA protects against subclinical lipopolysaccharide induced cardiac fibrosis in mice through inhibition of NADPH oxidase.
Topics: Abietanes; Acetophenones; Animals; Cardiomyopathies; Fibrosis; Lipopolysaccharides; Male; Mice, Inbred C57BL; Myocardium; NADPH Oxidase 2; Phosphoproteins; Protective Agents; Reactive Oxygen Species | 2018 |
The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy.
Topics: Abietanes; Animals; Apelin; Apelin Receptors; Apoptosis; Blood Pressure; Collagen; Fibrosis; Heart Function Tests; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Intercellular Signaling Peptides and Proteins; Male; Malondialdehyde; Matrix Metalloproteinase 2; Myocytes, Cardiac; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Superoxide Dismutase; Systole; Tissue Inhibitor of Metalloproteinase-2; Ultrasonography; Ventricular Remodeling | 2014 |
Tanshinon IIA injection accelerates tissue expansion by reducing the formation of the fibrous capsule.
Topics: Abietanes; Animals; Apoptosis; Cell Survival; Cells, Cultured; Drug Evaluation, Preclinical; Fibrosis; Immunosuppressive Agents; Injections, Intraperitoneal; Macrophages; Male; Neovascularization, Physiologic; Rats, Sprague-Dawley; Skin; Tissue Expansion | 2014 |
microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling.
Topics: Abietanes; Animals; Cells, Cultured; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Fibroblasts; Fibrosis; Male; MicroRNAs; Myocardial Infarction; Myocardium; Rats, Sprague-Dawley; Recovery of Function; RNA Interference; Smad3 Protein; Transfection; Transforming Growth Factor beta1; Up-Regulation; Ventricular Function, Left; Ventricular Remodeling | 2015 |
Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Topics: Abietanes; Animals; Blotting, Western; Disease Models, Animal; Drugs, Chinese Herbal; Fibrosis; Gene Expression; Immunohistochemistry; Kidney; Kidney Function Tests; Male; Medicine, Chinese Traditional; Nephrectomy; NF-kappa B; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Renal Insufficiency, Chronic; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2015 |
Tanshinone IIA Attenuates Renal Fibrosis after Acute Kidney Injury in a Mouse Model through Inhibition of Fibrocytes Recruitment.
Topics: Abietanes; Acute Kidney Injury; Animals; Fibrosis; Folic Acid; Kidney; Mice; Mice, Inbred C57BL | 2015 |
Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Biomarkers; Cytokines; Disease Models, Animal; Fibrosis; Heme Oxygenase-1; Inflammation; Inflammation Mediators; Male; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Rats | 2016 |
Effects of tanshinone IIA on transforming growth factor beta1-Smads signal pathway in renal interstitial fibroblasts of rats.
Topics: Abietanes; Animals; Cells, Cultured; Fibroblasts; Fibronectins; Fibrosis; Kidney; Phenanthrenes; Rats; RNA, Messenger; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2008 |
Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension.
Topics: Abietanes; Animals; Blood Pressure; Cardiovascular Agents; Collagen; Drugs, Chinese Herbal; Fibrosis; Gene Expression; Heart; Hypertension, Renovascular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Phytotherapy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Salvia miltiorrhiza; Tetrazoles; Tissue Inhibitor of Metalloproteinase-1; Valine; Valsartan | 2010 |
Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.
Topics: Abietanes; Animals; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Fibrosis; Heart Diseases; Hemodynamics; Hypertension, Renovascular; Male; Myocardium; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2011 |
Inhibitory effect of tanshinone II A on TGF II-β1-induced cardiac fibrosis.
Topics: Abietanes; Animals; Fibrosis; Heart; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2012 |